Essien Ofonime

Case Report: The Effect of Pentazocine Abuse in a Female Sickle Cell Disease Patient in Calabar, South-south, Nigeria

Akaba Kingsley, Essien Ofonime, Bassey O. Bassey, Onyeulor Eberechi, Edidiong Ekang, Edakabasi Akaba, Dike Adaobi & Omini Godwin · Journal of Pharmaceutical Research International · 2019

Background: Pentazocine is a synthetic opioid analgesic with mixed receptor activities. It acts as a partial agonist at the µ-receptor as well as being a kappa agonist. Its analgesic effect is estimated to be about 25-50% greater than that of morphine. Pentazocine acts has a shor...

Open access Research Article 10.9734/jpri/2019/v29i530247

Successful Management of Sickle Cell Disease Patient with Covid-19 Infection in a Low Resource Setting: Case Study

Akaba Kingsley, Edu C. Betta, Akaba Edakabasi, Essien Ofonime & Bibia Glory Philemon · Journal of Pharmaceutical Research International · 2021

Background: Sickle cell disease (SCD) patients have greater susceptibility to infections, they are reckoned to be vulnerable patients during the current COVID-19 pandemic. SCD patients are commonly affected by pulmonary complications such as acute chest syndrome (ACS), pulmonary...

Open access Research Article 10.9734/jpri/2021/v33i26A31475